The group intends to make the transaction the foundation of a wellness and consumer health business alongside general medicine, specialised products and dialysis. It plans to use its distribution networks to develop Ramo Pharm’s brands in Morocco and internationally.
The announcement concerns a signed agreement and does not establish that control has already transferred. According to Le Desk, neither the purchase price nor the completion timetable has been disclosed. Growth and operating synergies remain Sothema’s objectives.